The present invention provides methods to produce immunotoxins (ITs) and cytokines with a reduced ability to promote vascular leak syndrome (VLS). The invention also provides ITs and cytokines which have been mutated to lack amino acid sequences which induce VLS.

 
Web www.patentalert.com

< Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

> Modulators of TNF receptor associated factor (TRAF), their preparation and use

~ 00476